Wechselwirkungen · Norvir
Norvir 100 mg film-coated tablets · Abschnitt 4.5 · PDF-Seite 55–56
HOS-086491 · Präparat HOS-083284
55 Ritonavir effects on Non-antiretroviral Co-administered Medicinal Products Co-administered Medicinal Products Dose of Co-administered Medicinal Dose of Effect on Co- Effect on Co- Products (mg) NORVIR administered administered (mg) Medicinal Medicinal Products Products Cmax AUC beclomethasone). Moreover, in case of withdrawal of glucocorticoids progressive dose reduction may be required over a longer period. Dexamethasone Ritonavir dosed as a pharmacokinetic enhancer or as an antiretroviral agent inhibits CYP3A and as a result is expected to increase the plasma concentrations of dexamethasone. Careful monitoring of therapeutic and adverse effects is recommended when dexamethasone is concomitantly administered with ritonavir.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): dexamethasone (HOS-084535) beclomethasone (HOS-086334)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-11-11T18:35:00Z · SHA-256 82413695e61cf39577e85c47e382ee60197570a4ae72fe81d6e24e4211cd2d43 · Passage 583c78782a662f698dfa7073351d7e54382050be74d07dd6c457adfd36e23bc8 · Zeichen 59772–61113 im Abschnitt